Company page

Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. is a public company traded under the ticker KLRA in the American market. With a market capitalization of approximately $2.97 billion, the company focuses on developing innovative therapies. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.